Overview

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The study will compare the safety and efficacy of Bimatoprost and Latanoprost in patients with glaucoma or ocular hypertension
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Latanoprost
Ophthalmic Solutions
Tetrahydrozoline